Daniel F. Sarpong to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Daniel F. Sarpong has written about Diabetes Mellitus, Type 2.
Connection Strength
0.228
-
Ahmed F, Hammad SA, Lin JF, Gennaro TL, Gaspard AL, Sarpong DF, Onor IO. A1C Reduction in Patients Who Declined Pharmacist-Led Diabetes Management Services. J Pharm Pract. 2022 Jun; 35(3):413-421.
Score: 0.111
-
Liu CT, Ng MC, Rybin D, Adeyemo A, Bielinski SJ, Boerwinkle E, Borecki I, Cade B, Chen YD, Djousse L, Fornage M, Goodarzi MO, Grant SF, Guo X, Harris T, Kabagambe E, Kizer JR, Liu Y, Lunetta KL, Mukamal K, Nettleton JA, Pankow JS, Patel SR, Ramos E, Rasmussen-Torvik L, Rich SS, Rotimi CN, Sarpong D, Shriner D, Sims M, Zmuda JM, Redline S, Kao WH, Siscovick D, Florez JC, Rotter JI, Dupuis J, Wilson JG, Bowden DW, Meigs JB. Transferability and fine-mapping of glucose and insulin quantitative trait loci across populations: CARe, the Candidate Gene Association Resource. Diabetologia. 2012 Nov; 55(11):2970-84.
Score: 0.062
-
Fox ER, Sarpong DF, Cook JC, Samdarshi TE, Nagarajarao HS, Liebson PR, Sims M, Howard G, Garrison R, Taylor HA. The relation of diabetes, impaired fasting blood glucose, and insulin resistance to left ventricular structure and function in African Americans: the Jackson Heart Study. Diabetes Care. 2011 Feb; 34(2):507-9.
Score: 0.055